Comparing with the control LY52, compound 12u, with excellent activity both in the enzymatic inhibition assay and cell-based assay, could be used as lead compound for the further development of MMP inhibitors.
We next investigated whether the EGFP/HAC-based assay could be used to detect compounds that cause chromosome loss and mis-segregation.
The INF-γ-based assay could be a very useful addition to the diagnostic algorithm for children with suspected TB and may help to avoid unnecessary chemoprophylaxis.
In the current study, we used a non-human primate model to validate whether a non-invasive milk-based assay could be used to track gene expression in milk-producing cells.
The improved sensitivity of the image-based assay could be attributed to the limited available three-dimensional space where the image is captured (1 μm above the bottom of the well) minimizing the detection of fluorescent or quenching molecules.
The variation in findings based on CPE and MTT assay could be due to the fact that these extracts were able to inhibit the cytopatic effect without inhibiting the virus replication in Vero E6 cells.
Based on this assumption, the PRT4 assay could be combined with other assays, e.g. previously established PRTs [ 16, 20] to avoid the bias from the PSV rs187261177 in primer binding site and further improve the performance for CN determination.
Perhaps a relative lack of specificity for the phage assay (instead of an increased sensitivity of the phage assay), could be the alternative explanation for the higher response rates in all groups based on this assay.
Together, these findings show that the assay could be used as a primary screening tool to identify major genetic groups based on their genomic prints.
Passive assay could be extremely challenging in some scenarios.
Finally, we consider how the assay could be used in combination with other assays and outline the types of studies that are required to build the evidence base concerning its use.
